These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 33957266)

  • 1. Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing.
    Zhang B; Nasereddin J; McDonagh T; von Zeppelin D; Gleadall A; Alqahtani F; Bibb R; Belton P; Qi S
    Int J Pharm; 2021 Jul; 604():120626. PubMed ID: 33957266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Granule Feeding of Thermal Droplet Deposition 3D Printing of Porous Pharmaceutical Solid Dosage Forms Free of Plasticisers.
    McDonagh T; Belton P; Qi S
    Pharm Res; 2022 Mar; 39(3):599-610. PubMed ID: 35194719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the effects of geometric scaling and pore structure on drug dose and release of 3D printed solid dosage forms.
    McDonagh T; Belton P; Qi S
    Eur J Pharm Biopharm; 2022 Aug; 177():113-125. PubMed ID: 35779743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets.
    Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW
    Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
    Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
    Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple variable effects in the customisation of fused deposition modelling 3D-printed medicines: A design of experiments (DoE) approach.
    Dos Santos J; Deon M; da Silva GS; Beck RCR
    Int J Pharm; 2021 Mar; 597():120331. PubMed ID: 33540012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melt extrusion deposition (MED™) 3D printing technology - A paradigm shift in design and development of modified release drug products.
    Zheng Y; Deng F; Wang B; Wu Y; Luo Q; Zuo X; Liu X; Cao L; Li M; Lu H; Cheng S; Li X
    Int J Pharm; 2021 Jun; 602():120639. PubMed ID: 33901601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulating drug release from 3D printed dual-drug loaded polypills using challenging polymer compositions.
    McDonagh T; Belton P; Qi S
    Int J Pharm; 2023 Apr; 637():122895. PubMed ID: 36972779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
    Zhang P; Xu P; Chung S; Bandari S; Repka MA
    Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the effects of ink formulations of semi-solid extrusion 3D printing on the performance of printed solid dosage forms.
    Zhang B; Belton P; Teoh XY; Gleadall A; Bibb R; Qi S
    J Mater Chem B; 2023 Dec; 12(1):131-144. PubMed ID: 38050731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation.
    Zhang J; Yang W; Vo AQ; Feng X; Ye X; Kim DW; Repka MA
    Carbohydr Polym; 2017 Dec; 177():49-57. PubMed ID: 28962795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing?
    Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C
    Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.